Progenics Pharmaceuticals

PGNX

PGNX
Progenics Pharmaceuticals Stock Quote
$5.16 $0.61 13.4%
Price as of February 20, 2020, 4:30 p.m. EST View Interactive PGNX Charts

A biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases.

Interactive Chart


News & Analysis: Progenics Pharmaceuticals

The Fool has written over 100 articles on Progenics Pharmaceuticals.

All

Market Moves

Earnings